The test MRSA and MSSA directly from blood culture samples in about one hour, compared to between 48 and 72 hours with other methods, the company said.
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.
The activity follows a recent financing round that has enabled OncoDNA to build out its sales team as it courts new clients.
In PLOS this week: chromosomal insertion mechanisms, phylogeographic analysis of the Crimean Congo hemorrhagic fever virus, and more.
The researchers will use single-cell genomics and other approaches to generate information that could ultimately be used to diagnose, monitor, and treat disease.
Researchers found that mutations in this gene increased the risk of chronic obstructive pulmonary disease, bone marrow failure, and other conditions.
The companion test will let doctors identify the best treatment for CLL patients with 17p deletions, a subset that has historically lacked therapeutic options.
The partners will jointly market ASI's imaging platforms with Agilent FISH products to help customers create automated workflows.
The new system emphasizes the importance of tumor biology as an important prognostic indicator for women who undergo neoadjuvant therapy, the researchers said.
Using genomic data for pediatric low-grade gliomas, researchers uncovered a MYB-QKI fusion that appears to drive angiocentric glioma development.
CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.
Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.
Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.
In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.